Status:
COMPLETED
Platelet Drug Trial in Coronary Disease Progression
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Coronary Disease
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
To determine the effectiveness of the platelet inhibitor drugs dipyridamole and aspirin in reducing the angiographic progression of coronary artery disease over a five-year period and to test the pred...
Detailed Description
BACKGROUND: Coronary atherosclerosis is the leading cause of death in this country and the developed countries of the world. Although modern coronary care units have resulted in a markedly decreased ...
Eligibility Criteria
Patients aged 65 or less. Angiographically identified coronary heart disease
Key Trial Info
Start Date :
December 1 1979
Trial Type :
INTERVENTIONAL
End Date :
December 1 1982
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000496
Start Date
December 1 1979
End Date
December 1 1982
Last Update
November 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.